Activation of p21(CIP1/WAF1) in mammary epithelium accelerates mammary tumorigenesis and promotes lung metastasis

► Akt-activated p21 was primarily expressed in cytoplasm of cells in transgenic mice. ► Akt-activated p21 accelerated tumor onset in MMTV/neu mice. ► Akt-activated p21 promoted lung metastasis in MMTV/neu mice. ► In vivo evidence that cytoplasmic p21 functions as an oncogene. While p21 is well known...

Full description

Saved in:
Bibliographic Details
Published inBiochemical and biophysical research communications Vol. 403; no. 1; pp. 103 - 107
Main Authors Cheng, Xiaoyun, Xia, Weiya, Yang, Jer-Yen, Hsu, Jennifer L., Chou, Chao-Kai, Sun, Hui-Lung, Wyszomierski, Shannon L., Mills, Gordon B., Muller, William J., Yu, Dihua, Hung, Mien-Chie
Format Journal Article
LanguageEnglish
Published United States Elsevier Inc 03.12.2010
Subjects
Online AccessGet full text

Cover

Loading…
Abstract ► Akt-activated p21 was primarily expressed in cytoplasm of cells in transgenic mice. ► Akt-activated p21 accelerated tumor onset in MMTV/neu mice. ► Akt-activated p21 promoted lung metastasis in MMTV/neu mice. ► In vivo evidence that cytoplasmic p21 functions as an oncogene. While p21 is well known to inhibit cyclin-CDK activity in the nucleus and it has also been demonstrated to have oncogenic properties in different types of human cancers. In vitro studies showed that the oncogenic function of p21is closely related to its cytoplasmic localization. However, it is unclear whether cytoplasmic p21 contributes to tumorigenesis in vivo. To address this question, we generated transgenic mice expressing the Akt-phosphorylated form of p21 (p21T145D) in the mammary epithelium. The results showed that Akt-activated p21 was expressed in the cytoplasm of mammary epithelium. Overexpression of Akt-activated p21 accelerated tumor onset and promoted lung metastasis in MMTV/neu mice, providing evidence that p21, especially cytoplasmic phosphorylated p21, has an oncogenic role in promoting mammary tumorigenesis and metastasis.
AbstractList While p21 is well known to inhibit cyclin-CDK activity in the nucleus and it has also been demonstrated to have oncogenic properties in different types of human cancers. In vitro studies showed that the oncogenic function of p21is closely related to its cytoplasmic localization. However, it is unclear whether cytoplasmic p21 contributes to tumorigenesis in vivo . To address this question, we generated transgenic mice expressing the Akt-phosphorylated form of p21 (p21T145D) in the mammary epithelium. The results showed that Akt-activated p21 was expressed in the cytoplasm of mammary epithelium. Overexpression of Akt-activated p21 accelerated tumor onset and promoted lung metastasis in MMTV/ neu mice, providing evidence that p21, especially cytoplasmic phosphorylated p21, has an oncogenic role in promoting mammary tumorigenesis and metastasis.
► Akt-activated p21 was primarily expressed in cytoplasm of cells in transgenic mice. ► Akt-activated p21 accelerated tumor onset in MMTV/neu mice. ► Akt-activated p21 promoted lung metastasis in MMTV/neu mice. ► In vivo evidence that cytoplasmic p21 functions as an oncogene. While p21 is well known to inhibit cyclin-CDK activity in the nucleus and it has also been demonstrated to have oncogenic properties in different types of human cancers. In vitro studies showed that the oncogenic function of p21is closely related to its cytoplasmic localization. However, it is unclear whether cytoplasmic p21 contributes to tumorigenesis in vivo. To address this question, we generated transgenic mice expressing the Akt-phosphorylated form of p21 (p21T145D) in the mammary epithelium. The results showed that Akt-activated p21 was expressed in the cytoplasm of mammary epithelium. Overexpression of Akt-activated p21 accelerated tumor onset and promoted lung metastasis in MMTV/neu mice, providing evidence that p21, especially cytoplasmic phosphorylated p21, has an oncogenic role in promoting mammary tumorigenesis and metastasis.
While p21 is well known to inhibit cyclin-CDK activity in the nucleus and it has also been demonstrated to have oncogenic properties in different types of human cancers. In vitro studies showed that the oncogenic function of p21is closely related to its cytoplasmic localization. However, it is unclear whether cytoplasmic p21 contributes to tumorigenesis in vivo. To address this question, we generated transgenic mice expressing the Akt-phosphorylated form of p21 (p21T145D) in the mammary epithelium. The results showed that Akt-activated p21 was expressed in the cytoplasm of mammary epithelium. Overexpression of Akt-activated p21 accelerated tumor onset and promoted lung metastasis in MMTV/neu mice, providing evidence that p21, especially cytoplasmic phosphorylated p21, has an oncogenic role in promoting mammary tumorigenesis and metastasis.While p21 is well known to inhibit cyclin-CDK activity in the nucleus and it has also been demonstrated to have oncogenic properties in different types of human cancers. In vitro studies showed that the oncogenic function of p21is closely related to its cytoplasmic localization. However, it is unclear whether cytoplasmic p21 contributes to tumorigenesis in vivo. To address this question, we generated transgenic mice expressing the Akt-phosphorylated form of p21 (p21T145D) in the mammary epithelium. The results showed that Akt-activated p21 was expressed in the cytoplasm of mammary epithelium. Overexpression of Akt-activated p21 accelerated tumor onset and promoted lung metastasis in MMTV/neu mice, providing evidence that p21, especially cytoplasmic phosphorylated p21, has an oncogenic role in promoting mammary tumorigenesis and metastasis.
a-[ordm Akt-activated p21 was primarily expressed in cytoplasm of cells in transgenic mice. a-[ordm Akt-activated p21 accelerated tumor onset in MMTV/neu mice. a-[ordm Akt-activated p21 promoted lung metastasis in MMTV/neu mice. a-[ordm In vivo evidence that cytoplasmic p21 functions as an oncogene. While p21 is well known to inhibit cyclin-CDK activity in the nucleus and it has also been demonstrated to have oncogenic properties in different types of human cancers. In vitro studies showed that the oncogenic function of p21is closely related to its cytoplasmic localization. However, it is unclear whether cytoplasmic p21 contributes to tumorigenesis in vivo. To address this question, we generated transgenic mice expressing the Akt-phosphorylated form of p21 (p21T145D) in the mammary epithelium. The results showed that Akt-activated p21 was expressed in the cytoplasm of mammary epithelium. Overexpression of Akt-activated p21 accelerated tumor onset and promoted lung metastasis in MMTV/neu mice, providing evidence that p21, especially cytoplasmic phosphorylated p21, has an oncogenic role in promoting mammary tumorigenesis and metastasis.
While p21 is well known to inhibit cyclin-CDK activity in the nucleus and it has also been demonstrated to have oncogenic properties in different types of human cancers. In vitro studies showed that the oncogenic function of p21is closely related to its cytoplasmic localization. However, it is unclear whether cytoplasmic p21 contributes to tumorigenesis in vivo. To address this question, we generated transgenic mice expressing the Akt-phosphorylated form of p21 (p21T145D) in the mammary epithelium. The results showed that Akt-activated p21 was expressed in the cytoplasm of mammary epithelium. Overexpression of Akt-activated p21 accelerated tumor onset and promoted lung metastasis in MMTV/neu mice, providing evidence that p21, especially cytoplasmic phosphorylated p21, has an oncogenic role in promoting mammary tumorigenesis and metastasis.
Author Hsu, Jennifer L.
Hung, Mien-Chie
Cheng, Xiaoyun
Sun, Hui-Lung
Xia, Weiya
Chou, Chao-Kai
Muller, William J.
Wyszomierski, Shannon L.
Yang, Jer-Yen
Mills, Gordon B.
Yu, Dihua
AuthorAffiliation 2 Departments of System Biology, The University of Texas M. D. Anderson Cancer Center, Houston, TX 77030, USA
5 Center for Molecular Medicine and Graduate Institute of Cancer Biology, China Medical and University Hospital, Taichung 404, Taiwan
1 Department of Molecular and Cellular Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, TX 77030, USA
4 Department of Medicine and Biochemistry, McGill University, Montreal, Quebec, H3A1A1, Canada
3 Graduate School of Biomedical Sciences, The University of Texas, Houston, Texas 77030, USA
AuthorAffiliation_xml – name: 1 Department of Molecular and Cellular Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, TX 77030, USA
– name: 5 Center for Molecular Medicine and Graduate Institute of Cancer Biology, China Medical and University Hospital, Taichung 404, Taiwan
– name: 4 Department of Medicine and Biochemistry, McGill University, Montreal, Quebec, H3A1A1, Canada
– name: 2 Departments of System Biology, The University of Texas M. D. Anderson Cancer Center, Houston, TX 77030, USA
– name: 3 Graduate School of Biomedical Sciences, The University of Texas, Houston, Texas 77030, USA
Author_xml – sequence: 1
  givenname: Xiaoyun
  surname: Cheng
  fullname: Cheng, Xiaoyun
  organization: Department of Molecular and Cellular Oncology, The University of Texas, M. D. Anderson Cancer Center, Houston, TX 77030, USA
– sequence: 2
  givenname: Weiya
  surname: Xia
  fullname: Xia, Weiya
  organization: Department of Molecular and Cellular Oncology, The University of Texas, M. D. Anderson Cancer Center, Houston, TX 77030, USA
– sequence: 3
  givenname: Jer-Yen
  surname: Yang
  fullname: Yang, Jer-Yen
  organization: Department of Molecular and Cellular Oncology, The University of Texas, M. D. Anderson Cancer Center, Houston, TX 77030, USA
– sequence: 4
  givenname: Jennifer L.
  surname: Hsu
  fullname: Hsu, Jennifer L.
  organization: Department of Molecular and Cellular Oncology, The University of Texas, M. D. Anderson Cancer Center, Houston, TX 77030, USA
– sequence: 5
  givenname: Chao-Kai
  surname: Chou
  fullname: Chou, Chao-Kai
  organization: Department of Molecular and Cellular Oncology, The University of Texas, M. D. Anderson Cancer Center, Houston, TX 77030, USA
– sequence: 6
  givenname: Hui-Lung
  surname: Sun
  fullname: Sun, Hui-Lung
  organization: Department of Molecular and Cellular Oncology, The University of Texas, M. D. Anderson Cancer Center, Houston, TX 77030, USA
– sequence: 7
  givenname: Shannon L.
  surname: Wyszomierski
  fullname: Wyszomierski, Shannon L.
  organization: Department of Molecular and Cellular Oncology, The University of Texas, M. D. Anderson Cancer Center, Houston, TX 77030, USA
– sequence: 8
  givenname: Gordon B.
  surname: Mills
  fullname: Mills, Gordon B.
  organization: Department of Molecular and Cellular Oncology, The University of Texas, M. D. Anderson Cancer Center, Houston, TX 77030, USA
– sequence: 9
  givenname: William J.
  surname: Muller
  fullname: Muller, William J.
  organization: Department of Medicine and Biochemistry, McGill University, Montreal, Quebec, Canada H3A1A1
– sequence: 10
  givenname: Dihua
  surname: Yu
  fullname: Yu, Dihua
  organization: Department of Molecular and Cellular Oncology, The University of Texas, M. D. Anderson Cancer Center, Houston, TX 77030, USA
– sequence: 11
  givenname: Mien-Chie
  surname: Hung
  fullname: Hung, Mien-Chie
  email: mhung@mdanderson.org
  organization: Department of Molecular and Cellular Oncology, The University of Texas, M. D. Anderson Cancer Center, Houston, TX 77030, USA
BackLink https://www.ncbi.nlm.nih.gov/pubmed/21040707$$D View this record in MEDLINE/PubMed
BookMark eNqFkVFrFDEUhYNU7Lb6B3yQvKkPs00yM9kZkMKyWC0U9EHRt5C5c7PNMpNMk8yC_96Z3baoDxUCgXvPOZzkOyMnzjsk5DVnS864vNgtmybAUrDDYMmFfEYWnNUsE5wVJ2TBGJOZqPnPU3IW444xzgtZvyCn856t2GpB7taQ7F4n6x31hg6Cv9tcf-UXP9ZX_D21jva673X4RXGw6RY7O_ZUA2CHQSeMj-s09j7YLTqMNlLtWjoE3_tZ0o1uS3tMOk7HxpfkudFdxFf39zn5fvXx2-ZzdvPl0_VmfZNByaqU6SYvRV4BGoAmR4ZYotYCDHCDxhStYQWUAFUroAAhTZ2LomlWgkOFRpr8nFwec4ex6bEFdCnoTg3BzoWV11b9vXH2Vm39XuXTPwmRTwFv7wOCvxsxJtXbOL280w79GFXNVrwshaz-q6y4zCvJhJyUb_4s9djmAcgkqI4CCD7GgEaBTQc8U0fbKc7UzF7t1MxezewPs0O2-Mf6kP6k6cPRhBOKvcWgIlh0gK0NCEm13j5l_w2I3ctM
CitedBy_id crossref_primary_10_1016_j_steroids_2012_11_003
crossref_primary_10_18632_aging_202519
crossref_primary_10_1007_s12282_018_0913_1
crossref_primary_10_3233_CBM_160308
crossref_primary_10_3748_wjg_v21_i42_12150
crossref_primary_10_1097_SPC_0b013e328350f70c
crossref_primary_10_1186_s13058_017_0853_2
crossref_primary_10_1080_15384101_2023_2249702
crossref_primary_10_1111_bph_13045
crossref_primary_10_1016_j_biochi_2011_04_019
crossref_primary_10_1007_s00535_013_0900_4
crossref_primary_10_1186_s12885_015_1895_4
crossref_primary_10_2478_sjecr_2023_0005
crossref_primary_10_1242_jcs_089110
crossref_primary_10_18632_oncotarget_2844
crossref_primary_10_1093_jnci_djv077
crossref_primary_10_1016_j_jid_2021_03_036
crossref_primary_10_3390_cancers11091220
crossref_primary_10_1134_S000629791206003X
crossref_primary_10_1371_journal_pone_0085528
crossref_primary_10_1038_onc_2012_249
crossref_primary_10_1007_s12672_023_00855_4
crossref_primary_10_1016_j_cellsig_2018_03_010
crossref_primary_10_1155_2022_5498743
crossref_primary_10_1186_s13000_020_00947_7
crossref_primary_10_7717_peerj_6301
Cites_doi 10.1038/35060032
10.1158/1078-0432.CCR-08-0124
10.1006/excr.1994.1063
10.1038/sj.emboj.7601886
10.1016/S0960-9822(99)80265-6
10.1038/sj.cdd.4400706
10.1016/0092-8674(94)90379-4
10.1158/1078-0432.CCR-03-0527
10.1038/sj.onc.1205276
10.1073/pnas.181181198
10.1074/jbc.M109062200
10.4161/cc.1.4.138
10.1158/0008-5472.CAN-05-0189
10.1038/ncb1101-973
10.1038/sj.onc.1202148
10.1128/MCB.21.6.2203-2212.2001
10.1128/MCB.19.5.3842
10.1016/0092-8674(88)90184-5
10.1038/35060148
10.1016/S0092-8674(00)80405-5
10.1073/pnas.94.26.14590
10.1016/S0968-0004(02)02113-8
10.1038/366707a0
10.1016/S0304-3835(01)00847-3
10.1093/emboj/18.5.1223
10.1016/S0929-6646(09)60051-6
10.1038/sj.onc.1209432
ContentType Journal Article
Copyright 2010 Elsevier Inc.
Copyright © 2010 Elsevier Inc. All rights reserved.
2010 Elsevier Inc. All rights reserved. 2010
Copyright_xml – notice: 2010 Elsevier Inc.
– notice: Copyright © 2010 Elsevier Inc. All rights reserved.
– notice: 2010 Elsevier Inc. All rights reserved. 2010
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
7TO
H94
5PM
DOI 10.1016/j.bbrc.2010.10.126
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
Oncogenes and Growth Factors Abstracts
AIDS and Cancer Research Abstracts
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
Oncogenes and Growth Factors Abstracts
AIDS and Cancer Research Abstracts
DatabaseTitleList

MEDLINE - Academic
Oncogenes and Growth Factors Abstracts
MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Anatomy & Physiology
Chemistry
Biology
EISSN 1090-2104
EndPage 107
ExternalDocumentID PMC3001223
21040707
10_1016_j_bbrc_2010_10_126
S0006291X10020152
Genre Research Support, U.S. Gov't, Non-P.H.S
Research Support, Non-U.S. Gov't
Journal Article
Research Support, N.I.H., Extramural
GrantInformation_xml – fundername: NCI NIH HHS
  grantid: R01 CA109311
– fundername: NCI NIH HHS
  grantid: P50 CA098258
– fundername: NCI NIH HHS
  grantid: CA16672
– fundername: NCI NIH HHS
  grantid: P30 CA016672
– fundername: NCI NIH HHS
  grantid: P01 CA099031
GroupedDBID ---
--K
--M
-~X
.~1
0R~
1B1
1RT
1~.
1~5
23N
4.4
457
4G.
53G
5GY
5VS
6J9
7-5
71M
8P~
9JM
9M8
AABNK
AACTN
AAEDT
AAEDW
AAIAV
AAIKJ
AAKOC
AALRI
AAOAW
AAQFI
AAXUO
ABFNM
ABFRF
ABGSF
ABJNI
ABMAC
ABUDA
ABXDB
ABYKQ
ACDAQ
ACGFO
ACGFS
ACNCT
ACRLP
ADBBV
ADEZE
ADIYS
ADMUD
ADUVX
AEBSH
AEFWE
AEHWI
AEKER
AENEX
AFFNX
AFKWA
AFTJW
AFXIZ
AGHFR
AGUBO
AGYEJ
AHHHB
AIEXJ
AIKHN
AITUG
AJBFU
AJOXV
ALMA_UNASSIGNED_HOLDINGS
AMFUW
AMRAJ
AXJTR
BKOJK
BLXMC
CS3
D0L
DM4
DOVZS
EBS
EFBJH
EFLBG
EJD
EO8
EO9
EP2
EP3
F5P
FDB
FIRID
FNPLU
FYGXN
G-Q
HZ~
IHE
J1W
K-O
KOM
L7B
LG5
LX2
M41
MO0
N9A
O-L
O9-
OAUVE
OZT
P-8
P-9
P2P
PC.
Q38
RIG
RNS
ROL
RPZ
SCC
SDF
SDG
SDP
SES
SPCBC
SSU
SSZ
T5K
TWZ
WH7
XPP
XSW
ZA5
ZMT
~02
~G-
.55
.GJ
.HR
1CY
3O-
AAHBH
AAQXK
AATTM
AAXKI
AAYJJ
AAYWO
AAYXX
ABDPE
ABEFU
ABWVN
ACKIV
ACRPL
ACVFH
ADCNI
ADFGL
ADNMO
AEIPS
AEUPX
AFJKZ
AFPUW
AGCQF
AGQPQ
AGRDE
AGRNS
AIGII
AIIUN
AKBMS
AKRWK
AKYEP
ANKPU
APXCP
ASPBG
AVWKF
AZFZN
BNPGV
CAG
CITATION
COF
FEDTE
FGOYB
G-2
GBLVA
HLW
HVGLF
MVM
OHT
R2-
SBG
SEW
SSH
UQL
WUQ
X7M
Y6R
ZGI
ZKB
~KM
CGR
CUY
CVF
ECM
EFKBS
EIF
NPM
7X8
7TO
H94
5PM
ID FETCH-LOGICAL-c508t-ab35238cefccb3e0ee5eaa2cfc1feff4df04c5cc8d2c4c26f9324bb721c8ef6f3
IEDL.DBID .~1
ISSN 0006-291X
1090-2104
IngestDate Thu Aug 21 18:07:59 EDT 2025
Sun Aug 24 03:47:51 EDT 2025
Mon Jul 21 10:31:33 EDT 2025
Mon Jul 21 06:04:10 EDT 2025
Thu Apr 24 23:02:28 EDT 2025
Tue Jul 01 04:24:12 EDT 2025
Fri Feb 23 02:34:28 EST 2024
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords p21
Language English
License https://www.elsevier.com/tdm/userlicense/1.0
Copyright © 2010 Elsevier Inc. All rights reserved.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c508t-ab35238cefccb3e0ee5eaa2cfc1feff4df04c5cc8d2c4c26f9324bb721c8ef6f3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ObjectType-Article-2
ObjectType-Feature-1
PMID 21040707
PQID 816386026
PQPubID 23479
PageCount 5
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_3001223
proquest_miscellaneous_907155268
proquest_miscellaneous_816386026
pubmed_primary_21040707
crossref_citationtrail_10_1016_j_bbrc_2010_10_126
crossref_primary_10_1016_j_bbrc_2010_10_126
elsevier_sciencedirect_doi_10_1016_j_bbrc_2010_10_126
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2010-12-03
PublicationDateYYYYMMDD 2010-12-03
PublicationDate_xml – month: 12
  year: 2010
  text: 2010-12-03
  day: 03
PublicationDecade 2010
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle Biochemical and biophysical research communications
PublicationTitleAlternate Biochem Biophys Res Commun
PublicationYear 2010
Publisher Elsevier Inc
Publisher_xml – name: Elsevier Inc
References Hutchinson, Jin, Cardiff, Woodgett, Muller (b0015) 2001; 21
Zhou, Liao, Xia, Spohn, Lee, Hung (b0055) 2001; 3
Suzuki, Kawano, Hayashida, Hayasaki, Tsutomi, Akahane (b0085) 2000; 7
Kane, Shapiro, Stokoe, Weiss (b0020) 1999; 9
Rahmani, Grant (b0105) 2002; 1
Dulic, Kaufmann, Wilson, Tlsty, Lees, Harper, Elledge, Reed (b0070) 1994; 76
Kumar, Hung (b0010) 2005; 65
Suzuki, Tsutomi, Yamamoto, Shibutani, Akahane (b0080) 1999; 19
Mayo, Donner (b0045) 2001; 98
Datta, Dudek, Tao, Masters, Fu, Gotoh, Greenberg (b0025) 1997; 91
Ashcroft, Ludwig, Woods, Copeland, Weber, MacRae, Vousden (b0040) 2002; 21
Burgering, Kops (b0030) 2002; 27
Li, Dowbenko, Lasky (b0095) 2002; 277
Muller, Sinn, Pattengale, Wallace, Leder (b0120) 1988; 54
De la Cueva, Garcia-Cao, Herranz, Lopez, Garcia-Palencia, Flores, Serrano, Fernandez-Piqueras, Martin-Caballero (b0125) 2006; 25
Xia, Chen, Zhou, Sun, Lee, Liao, Zhou, Hung (b0110) 2004; 10
Noda, Ning, Venable, Pereira-Smith, Smith (b0065) 1994; 211
Liu, Yeh, Zhu, Leversha, Cordon-Cardo, Ghossein, Singh, Holland, Koff (b0135) 2007; 26
Zhou, Liao, Xia, Zou, Spohn, Hung (b0050) 2001; 3
Roninson (b0075) 2002; 179
Huang, Hung (b0005) 2009; 108
Gu, Turck, Morgan (b0060) 1993; 366
El-Deiry (b0100) 2001; 3
Yang, Hung (b0035) 2009; 15
Deng, Xia, Hung (b0115) 1998; 17
Wang, Elson, Leder (b0130) 1997; 94
Asada, Yamada, Ichijo, Delia, Miyazono, Fukumuro, Mizutani (b0090) 1999; 18
Kane (10.1016/j.bbrc.2010.10.126_b0020) 1999; 9
Hutchinson (10.1016/j.bbrc.2010.10.126_b0015) 2001; 21
Suzuki (10.1016/j.bbrc.2010.10.126_b0080) 1999; 19
Gu (10.1016/j.bbrc.2010.10.126_b0060) 1993; 366
Deng (10.1016/j.bbrc.2010.10.126_b0115) 1998; 17
Liu (10.1016/j.bbrc.2010.10.126_b0135) 2007; 26
Datta (10.1016/j.bbrc.2010.10.126_b0025) 1997; 91
Mayo (10.1016/j.bbrc.2010.10.126_b0045) 2001; 98
De la Cueva (10.1016/j.bbrc.2010.10.126_b0125) 2006; 25
Zhou (10.1016/j.bbrc.2010.10.126_b0055) 2001; 3
Muller (10.1016/j.bbrc.2010.10.126_b0120) 1988; 54
Zhou (10.1016/j.bbrc.2010.10.126_b0050) 2001; 3
Noda (10.1016/j.bbrc.2010.10.126_b0065) 1994; 211
Wang (10.1016/j.bbrc.2010.10.126_b0130) 1997; 94
Burgering (10.1016/j.bbrc.2010.10.126_b0030) 2002; 27
Rahmani (10.1016/j.bbrc.2010.10.126_b0105) 2002; 1
Suzuki (10.1016/j.bbrc.2010.10.126_b0085) 2000; 7
Xia (10.1016/j.bbrc.2010.10.126_b0110) 2004; 10
Huang (10.1016/j.bbrc.2010.10.126_b0005) 2009; 108
Roninson (10.1016/j.bbrc.2010.10.126_b0075) 2002; 179
Li (10.1016/j.bbrc.2010.10.126_b0095) 2002; 277
Asada (10.1016/j.bbrc.2010.10.126_b0090) 1999; 18
El-Deiry (10.1016/j.bbrc.2010.10.126_b0100) 2001; 3
Ashcroft (10.1016/j.bbrc.2010.10.126_b0040) 2002; 21
Dulic (10.1016/j.bbrc.2010.10.126_b0070) 1994; 76
Yang (10.1016/j.bbrc.2010.10.126_b0035) 2009; 15
Kumar (10.1016/j.bbrc.2010.10.126_b0010) 2005; 65
References_xml – volume: 7
  start-page: 721
  year: 2000
  end-page: 728
  ident: b0085
  article-title: Procaspase 3/p21 complex formation to resist fas-mediated cell death is initiated as a result of the phosphorylation of p21 by protein kinase A
  publication-title: Cell Death Differ.
– volume: 211
  start-page: 90
  year: 1994
  end-page: 98
  ident: b0065
  article-title: Cloning of senescent cell-derived inhibitors of DNA synthesis using an expression screen
  publication-title: Exp. Cell Res.
– volume: 3
  start-page: E71
  year: 2001
  end-page: E73
  ident: b0100
  article-title: Akt takes centre stage in cell-cycle deregulation
  publication-title: Nat. Cell Biol.
– volume: 94
  start-page: 14590
  year: 1997
  end-page: 14595
  ident: b0130
  article-title: Loss of p21 increases sensitivity to ionizing radiation and delays the onset of lymphoma in atm-deficient mice
  publication-title: Proc. Natl. Acad. Sci. USA
– volume: 27
  start-page: 352
  year: 2002
  end-page: 360
  ident: b0030
  article-title: Cell cycle and death control: long live Forkheads
  publication-title: Trends Biochem. Sci.
– volume: 76
  start-page: 1013
  year: 1994
  end-page: 1023
  ident: b0070
  article-title: p53-dependent inhibition of cyclin-dependent kinase activities in human fibroblasts during radiation-induced G1 arrest
  publication-title: Cell
– volume: 17
  start-page: 2167
  year: 1998
  end-page: 2175
  ident: b0115
  article-title: Adenovirus 5 E1A-mediated tumor suppression associated with E1A-mediated apoptosis in vivo
  publication-title: Oncogene
– volume: 179
  start-page: 1
  year: 2002
  end-page: 14
  ident: b0075
  article-title: Oncogenic functions of tumour suppressor p21(Waf1/Cip1/Sdi1): association with cell senescence and tumour-promoting activities of stromal fibroblasts
  publication-title: Cancer Lett.
– volume: 3
  start-page: 973
  year: 2001
  end-page: 982
  ident: b0050
  article-title: HER-2/neu induces p53 ubiquitination via Akt-mediated MDM2 phosphorylation
  publication-title: Nat. Cell Biol.
– volume: 65
  start-page: 2511
  year: 2005
  end-page: 2515
  ident: b0010
  article-title: Signaling intricacies take center stage in cancer cells
  publication-title: Cancer Res.
– volume: 98
  start-page: 11598
  year: 2001
  end-page: 11603
  ident: b0045
  article-title: A phosphatidylinositol 3-kinase/Akt pathway promotes translocation of Mdm2 from the cytoplasm to the nucleus
  publication-title: Proc. Natl. Acad. Sci. USA
– volume: 18
  start-page: 1223
  year: 1999
  end-page: 1234
  ident: b0090
  article-title: Apoptosis inhibitory activity of cytoplasmic p21(Cip1/WAF1) in monocytic differentiation
  publication-title: EMBO J.
– volume: 25
  start-page: 4128
  year: 2006
  end-page: 4132
  ident: b0125
  article-title: Tumorigenic activity of p21Waf1/Cip1 in thymic lymphoma
  publication-title: Oncogene
– volume: 3
  start-page: 245
  year: 2001
  end-page: 252
  ident: b0055
  article-title: Cytoplasmic localization of p21Cip1/WAF1 by Akt-induced phosphorylation in HER-2/neu-overexpressing cells
  publication-title: Nat. Cell Biol.
– volume: 1
  start-page: 273
  year: 2002
  end-page: 281
  ident: b0105
  article-title: UCN-01 (7-hydroxystauorsporine) blocks PMA-induced maturation and reciprocally promotes apoptosis in human myelomonocytic leukemia cells (U937)
  publication-title: Cell Cycle
– volume: 366
  start-page: 707
  year: 1993
  end-page: 710
  ident: b0060
  article-title: Inhibition of CDK2 activity in vivo by an associated 20K regulatory subunit
  publication-title: Nature
– volume: 15
  start-page: 752
  year: 2009
  end-page: 757
  ident: b0035
  article-title: A new fork for clinical application: targeting forkhead transcription factors in cancer
  publication-title: Clin. Cancer Res.
– volume: 21
  start-page: 1955
  year: 2002
  end-page: 1962
  ident: b0040
  article-title: Phosphorylation of HDM2 by Akt
  publication-title: Oncogene
– volume: 91
  start-page: 231
  year: 1997
  end-page: 241
  ident: b0025
  article-title: Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery
  publication-title: Cell
– volume: 10
  start-page: 3815
  year: 2004
  end-page: 3824
  ident: b0110
  article-title: Phosphorylation/cytoplasmic localization of p21Cip1/WAF1 is associated with HER2/neu overexpression and provides a novel combination predictor for poor prognosis in breast cancer patients
  publication-title: Clin. Cancer Res.
– volume: 9
  start-page: 601
  year: 1999
  end-page: 604
  ident: b0020
  article-title: Induction of NF-kappaB by the Akt/PKB kinase
  publication-title: Curr. Biol.
– volume: 54
  start-page: 105
  year: 1988
  end-page: 115
  ident: b0120
  article-title: Single-step induction of mammary adenocarcinoma in transgenic mice bearing the activated c-neu oncogene
  publication-title: Cell
– volume: 19
  start-page: 3842
  year: 1999
  end-page: 3847
  ident: b0080
  article-title: Mitochondrial regulation of cell death: mitochondria are essential for procaspase 3-p21 complex formation to resist Fas-mediated cell death
  publication-title: Mol. Cell. Biol.
– volume: 21
  start-page: 2203
  year: 2001
  end-page: 2212
  ident: b0015
  article-title: Activation of Akt (protein kinase B) in mammary epithelium provides a critical cell survival signal required for tumor progression
  publication-title: Mol. Cell. Biol.
– volume: 26
  start-page: 4683
  year: 2007
  end-page: 4693
  ident: b0135
  article-title: Somatic cell type specific gene transfer reveals a tumor-promoting function for p21(Waf1/Cip1)
  publication-title: EMBO J.
– volume: 108
  start-page: 180
  year: 2009
  end-page: 194
  ident: b0005
  article-title: Induction of Akt activity by chemotherapy confers acquired resistance
  publication-title: J. Formos. Med. Assoc.
– volume: 277
  start-page: 11352
  year: 2002
  end-page: 11361
  ident: b0095
  article-title: AKT/PKB phosphorylation of p21Cip/WAF1 enhances protein stability of p21Cip/WAF1 and promotes cell survival
  publication-title: J. Biol. Chem.
– volume: 3
  start-page: 245
  year: 2001
  ident: 10.1016/j.bbrc.2010.10.126_b0055
  article-title: Cytoplasmic localization of p21Cip1/WAF1 by Akt-induced phosphorylation in HER-2/neu-overexpressing cells
  publication-title: Nat. Cell Biol.
  doi: 10.1038/35060032
– volume: 15
  start-page: 752
  year: 2009
  ident: 10.1016/j.bbrc.2010.10.126_b0035
  article-title: A new fork for clinical application: targeting forkhead transcription factors in cancer
  publication-title: Clin. Cancer Res.
  doi: 10.1158/1078-0432.CCR-08-0124
– volume: 211
  start-page: 90
  year: 1994
  ident: 10.1016/j.bbrc.2010.10.126_b0065
  article-title: Cloning of senescent cell-derived inhibitors of DNA synthesis using an expression screen
  publication-title: Exp. Cell Res.
  doi: 10.1006/excr.1994.1063
– volume: 26
  start-page: 4683
  year: 2007
  ident: 10.1016/j.bbrc.2010.10.126_b0135
  article-title: Somatic cell type specific gene transfer reveals a tumor-promoting function for p21(Waf1/Cip1)
  publication-title: EMBO J.
  doi: 10.1038/sj.emboj.7601886
– volume: 9
  start-page: 601
  year: 1999
  ident: 10.1016/j.bbrc.2010.10.126_b0020
  article-title: Induction of NF-kappaB by the Akt/PKB kinase
  publication-title: Curr. Biol.
  doi: 10.1016/S0960-9822(99)80265-6
– volume: 7
  start-page: 721
  year: 2000
  ident: 10.1016/j.bbrc.2010.10.126_b0085
  article-title: Procaspase 3/p21 complex formation to resist fas-mediated cell death is initiated as a result of the phosphorylation of p21 by protein kinase A
  publication-title: Cell Death Differ.
  doi: 10.1038/sj.cdd.4400706
– volume: 76
  start-page: 1013
  year: 1994
  ident: 10.1016/j.bbrc.2010.10.126_b0070
  article-title: p53-dependent inhibition of cyclin-dependent kinase activities in human fibroblasts during radiation-induced G1 arrest
  publication-title: Cell
  doi: 10.1016/0092-8674(94)90379-4
– volume: 10
  start-page: 3815
  year: 2004
  ident: 10.1016/j.bbrc.2010.10.126_b0110
  article-title: Phosphorylation/cytoplasmic localization of p21Cip1/WAF1 is associated with HER2/neu overexpression and provides a novel combination predictor for poor prognosis in breast cancer patients
  publication-title: Clin. Cancer Res.
  doi: 10.1158/1078-0432.CCR-03-0527
– volume: 21
  start-page: 1955
  year: 2002
  ident: 10.1016/j.bbrc.2010.10.126_b0040
  article-title: Phosphorylation of HDM2 by Akt
  publication-title: Oncogene
  doi: 10.1038/sj.onc.1205276
– volume: 98
  start-page: 11598
  year: 2001
  ident: 10.1016/j.bbrc.2010.10.126_b0045
  article-title: A phosphatidylinositol 3-kinase/Akt pathway promotes translocation of Mdm2 from the cytoplasm to the nucleus
  publication-title: Proc. Natl. Acad. Sci. USA
  doi: 10.1073/pnas.181181198
– volume: 277
  start-page: 11352
  year: 2002
  ident: 10.1016/j.bbrc.2010.10.126_b0095
  article-title: AKT/PKB phosphorylation of p21Cip/WAF1 enhances protein stability of p21Cip/WAF1 and promotes cell survival
  publication-title: J. Biol. Chem.
  doi: 10.1074/jbc.M109062200
– volume: 1
  start-page: 273
  year: 2002
  ident: 10.1016/j.bbrc.2010.10.126_b0105
  article-title: UCN-01 (7-hydroxystauorsporine) blocks PMA-induced maturation and reciprocally promotes apoptosis in human myelomonocytic leukemia cells (U937)
  publication-title: Cell Cycle
  doi: 10.4161/cc.1.4.138
– volume: 65
  start-page: 2511
  year: 2005
  ident: 10.1016/j.bbrc.2010.10.126_b0010
  article-title: Signaling intricacies take center stage in cancer cells
  publication-title: Cancer Res.
  doi: 10.1158/0008-5472.CAN-05-0189
– volume: 3
  start-page: 973
  year: 2001
  ident: 10.1016/j.bbrc.2010.10.126_b0050
  article-title: HER-2/neu induces p53 ubiquitination via Akt-mediated MDM2 phosphorylation
  publication-title: Nat. Cell Biol.
  doi: 10.1038/ncb1101-973
– volume: 17
  start-page: 2167
  year: 1998
  ident: 10.1016/j.bbrc.2010.10.126_b0115
  article-title: Adenovirus 5 E1A-mediated tumor suppression associated with E1A-mediated apoptosis in vivo
  publication-title: Oncogene
  doi: 10.1038/sj.onc.1202148
– volume: 21
  start-page: 2203
  year: 2001
  ident: 10.1016/j.bbrc.2010.10.126_b0015
  article-title: Activation of Akt (protein kinase B) in mammary epithelium provides a critical cell survival signal required for tumor progression
  publication-title: Mol. Cell. Biol.
  doi: 10.1128/MCB.21.6.2203-2212.2001
– volume: 19
  start-page: 3842
  year: 1999
  ident: 10.1016/j.bbrc.2010.10.126_b0080
  article-title: Mitochondrial regulation of cell death: mitochondria are essential for procaspase 3-p21 complex formation to resist Fas-mediated cell death
  publication-title: Mol. Cell. Biol.
  doi: 10.1128/MCB.19.5.3842
– volume: 54
  start-page: 105
  year: 1988
  ident: 10.1016/j.bbrc.2010.10.126_b0120
  article-title: Single-step induction of mammary adenocarcinoma in transgenic mice bearing the activated c-neu oncogene
  publication-title: Cell
  doi: 10.1016/0092-8674(88)90184-5
– volume: 3
  start-page: E71
  year: 2001
  ident: 10.1016/j.bbrc.2010.10.126_b0100
  article-title: Akt takes centre stage in cell-cycle deregulation
  publication-title: Nat. Cell Biol.
  doi: 10.1038/35060148
– volume: 91
  start-page: 231
  year: 1997
  ident: 10.1016/j.bbrc.2010.10.126_b0025
  article-title: Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery
  publication-title: Cell
  doi: 10.1016/S0092-8674(00)80405-5
– volume: 94
  start-page: 14590
  year: 1997
  ident: 10.1016/j.bbrc.2010.10.126_b0130
  article-title: Loss of p21 increases sensitivity to ionizing radiation and delays the onset of lymphoma in atm-deficient mice
  publication-title: Proc. Natl. Acad. Sci. USA
  doi: 10.1073/pnas.94.26.14590
– volume: 27
  start-page: 352
  year: 2002
  ident: 10.1016/j.bbrc.2010.10.126_b0030
  article-title: Cell cycle and death control: long live Forkheads
  publication-title: Trends Biochem. Sci.
  doi: 10.1016/S0968-0004(02)02113-8
– volume: 366
  start-page: 707
  year: 1993
  ident: 10.1016/j.bbrc.2010.10.126_b0060
  article-title: Inhibition of CDK2 activity in vivo by an associated 20K regulatory subunit
  publication-title: Nature
  doi: 10.1038/366707a0
– volume: 179
  start-page: 1
  year: 2002
  ident: 10.1016/j.bbrc.2010.10.126_b0075
  article-title: Oncogenic functions of tumour suppressor p21(Waf1/Cip1/Sdi1): association with cell senescence and tumour-promoting activities of stromal fibroblasts
  publication-title: Cancer Lett.
  doi: 10.1016/S0304-3835(01)00847-3
– volume: 18
  start-page: 1223
  year: 1999
  ident: 10.1016/j.bbrc.2010.10.126_b0090
  article-title: Apoptosis inhibitory activity of cytoplasmic p21(Cip1/WAF1) in monocytic differentiation
  publication-title: EMBO J.
  doi: 10.1093/emboj/18.5.1223
– volume: 108
  start-page: 180
  year: 2009
  ident: 10.1016/j.bbrc.2010.10.126_b0005
  article-title: Induction of Akt activity by chemotherapy confers acquired resistance
  publication-title: J. Formos. Med. Assoc.
  doi: 10.1016/S0929-6646(09)60051-6
– volume: 25
  start-page: 4128
  year: 2006
  ident: 10.1016/j.bbrc.2010.10.126_b0125
  article-title: Tumorigenic activity of p21Waf1/Cip1 in thymic lymphoma
  publication-title: Oncogene
  doi: 10.1038/sj.onc.1209432
SSID ssj0011469
Score 2.1435614
Snippet ► Akt-activated p21 was primarily expressed in cytoplasm of cells in transgenic mice. ► Akt-activated p21 accelerated tumor onset in MMTV/neu mice. ►...
While p21 is well known to inhibit cyclin-CDK activity in the nucleus and it has also been demonstrated to have oncogenic properties in different types of...
a-[ordm Akt-activated p21 was primarily expressed in cytoplasm of cells in transgenic mice. a-[ordm Akt-activated p21 accelerated tumor onset in MMTV/neu mice....
SourceID pubmedcentral
proquest
pubmed
crossref
elsevier
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 103
SubjectTerms Animals
Breast Neoplasms - metabolism
Breast Neoplasms - pathology
Cell Transformation, Neoplastic - metabolism
Cell Transformation, Neoplastic - pathology
Cyclin-Dependent Kinase Inhibitor p21 - biosynthesis
Epithelium - metabolism
Epithelium - pathology
Female
Humans
Lung metastasis
Lung Neoplasms - metabolism
Lung Neoplasms - secondary
Mammary Neoplasms, Experimental - metabolism
Mammary Neoplasms, Experimental - pathology
Mammary tumorigenesis
Mice
Mice, Transgenic
Mouse mammary tumor virus
p21
PKB/Akt
Proto-Oncogene Proteins c-akt - metabolism
Title Activation of p21(CIP1/WAF1) in mammary epithelium accelerates mammary tumorigenesis and promotes lung metastasis
URI https://dx.doi.org/10.1016/j.bbrc.2010.10.126
https://www.ncbi.nlm.nih.gov/pubmed/21040707
https://www.proquest.com/docview/816386026
https://www.proquest.com/docview/907155268
https://pubmed.ncbi.nlm.nih.gov/PMC3001223
Volume 403
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9NAEF5VRQguCFoeaUu1B4RAKMSP9cY-mogoBVFxoCI3a5-qUeyYxjn00t_embXXIqD2wM3yzsqOZzzzTTzzDSFvYshJEglJTqgzDgmKTsdCwnulpY4lT6YicbSL38754oJ9WSbLPTLzvTBYVtn7_s6nO2_dn5n0T3PSlCX2-AY8ysIlkohCUEM_zNgUrfzjzVDmgU23PQTmY5TuG2e6Gi8pr1RX3uV4Fvhdwelf8Pl3DeUfQWn-lDzp0STNuxt-RvZMfUAO8xoy6eqavqWuvtP9cX5AHn7yR49mfsrbIfmdKz_gjK4tbaLw3ezsezj5mc_D97SsaSVcdxs1DXZvrMptRYVSEKyQY2IzLLfbCmdsoecsN1TUmjau0A9EVuBPaGVaAUAUFp-Ti_nnH7PFuB_DMFaA3lrUHWSrqTJWKRmbwJjECBEpq0JrrGXaBkwlSqU6UkxF3AIkZFJCaqlSY7mNX5D9el2bV4SKVEx1JnWQCcPiwKRwAeSLz3gG0IvxEQn98y9Uz1GOozJWhS9G-1WgzgrUmTsXwZ4Pw56mY-i4Vzrxai127KyAEHLvPuptoAAN4VcVUZv1dlOkiGhxkNfdIhnguAR5dUbkZWc1w51Cxs2QcWlEpjv2NAgg_ffuSl1eOhrw2H0WjY_-8xcdk8eRL82JT8h-e7U1rwFgtfLUvUGn5EF-9nVxfgtYYyc7
linkProvider Elsevier
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lj9MwELaWRWi5INjlUZ4-AAKh0sRJ3OTAoRSqln2Iw67oLWs7tghq0rBNhfbCn-IPMuPEEQXtHpD2VsV26njseSTffEPI8wBikkhCkONnCYcAJYv7QsK5ymQWSB4NRWRpFw-P-PQk_DSP5lvkl8uFQVhlq_sbnW61dXtl0K7moMpzzPH1OEv8OZKIglFjLbJyX5__gLht9W72AYT8grHJx-PxtN-WFugr8EhqnA9EYLHSRikZaE_rSAvBlFG-0caEmfFCFSkVZ0yFinEDbk4oJYRLKtaGmwDue41cD0FdYNmEtz87XAlm-bY-N-_j9NpMnQZUJuWZavBkltiBX2QN__V2_wZt_mEFJ7fJrdZ9paNmhe6QLV3ukr1RCaF7cU5fUgsotW_qd8mN9-7XztiVldsj30fKVVSjS0Mr5r8azz77gy-jif-a5iUthE2no7rCdJFFvi6oUAqsI5JarLrmel1gUS9U1fmKijKjlUUWQpcFKDBa6FqA5wuNd8nJlQjnHtkul6V-QKiIxTBLZOYlQoeBp2P4AySoT3gCvl7Ie8R365-qlhQda3MsUod--5aizFKUmb3GYMybbkzVUIJc2jtyYk03NnYKNuvScdTtgRQkhJ9xRKmX61UaowuNlcMu7pKA4xghkU-P3G92TTdTCPFDpHjqkeHGfuo6IN_4ZkuZf7W844H9Dhs8_M8nekZ2pseHB-nB7Gj_EbnJHC4oeEy267O1fgLeXS2f2tNEyelVH9_feNNnDQ
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Activation+of+p21%28CIP1%2FWAF1%29+in+Mammary+Epithelium+Accelerates+Mammary+Tumorigenesis+and+Promotes+Lung+Metastasis&rft.jtitle=Biochemical+and+biophysical+research+communications&rft.au=Cheng%2C+Xiaoyun&rft.au=Xia%2C+Weiya&rft.au=Yang%2C+Jer-Yen&rft.au=Hsu%2C+Jennifer+L.&rft.date=2010-12-03&rft.issn=0006-291X&rft.eissn=1090-2104&rft.volume=403&rft.issue=1&rft.spage=103&rft.epage=107&rft_id=info:doi/10.1016%2Fj.bbrc.2010.10.126&rft_id=info%3Apmid%2F21040707&rft.externalDocID=PMC3001223
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0006-291X&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0006-291X&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0006-291X&client=summon